Cancer of Unknown Primary Site
Cet article passe en revue les perspectives offertes par les nouveaux outils de diagnostic (imagerie, immunohistochimie, profils moléculaires) pour la prise en charge des patients atteints d'un cancer de site primitif inconnu
This review summarizes how sophisticated imaging, immunohistochemical testing, and molecular-profiling tools are changing the approach to cancer of unknown primary site. Increasingly, treatment decisions are personalized on the basis of the mutational status of a patient's tumor.
New England Journal of Medicine , résumé, 2013